Characterization of Bet v 1-related allergens from kiwifruit relevant for patients with combined kiwifruit and birch pollen allergy

被引:49
|
作者
Oberhuber, Christina [2 ]
Bulley, Sean M. [3 ]
Ballmer-Weber, Barbara K. [4 ]
Bublin, Merima [1 ]
Gaier, Sonja [1 ]
DeWitt, Asa Marknell [5 ]
Briza, Peter [6 ]
Hofstetter, Gerlinde [1 ]
Lidholm, Jonas [5 ]
Vieths, Stefan [7 ]
Hoffmann-Sommergruber, Karin [1 ]
机构
[1] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria
[2] Biomay AG, Vienna, Austria
[3] Hort & Food Res Inst New Zealand Ltd, Auckland, New Zealand
[4] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland
[5] Phadia AB, Uppsala, Sweden
[6] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria
[7] Paul Ehrlich Inst, D-6070 Langen, Germany
关键词
Bet v 1; Food allergy; Kiwifruit; Pollen allergy; Recombinant allergen;
D O I
10.1002/mnfr.200800146
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Allergy to kiwifruit appears to have become more common in Europe and elsewhere during the past several years. Seven allergens have been identified from kiwifruit so far, with actinidin, kiwellin and the thaumatin-like protein as the most relevant ones. In contrast to other fruits, no Bet v 1 homologues were characterized from kiwifruit so far. We cloned, purified, and characterized recombinant Bet v 1-homologous allergens from green (Actinidia deliciosa, Act d 8) and gold (Actinidia chinensis, Act c 8) kiwifruit, and confirmed the presence of its natural counterpart by inhibition assays. Well-characterized recombinant Act d 8 and Act c 8 were recognized by birch pollen/kiwifruit (confirmed by double-blind placebo-controlled food challenge) allergic patients in IgE immunoblots and ELISA experiments. The present data point out that Bet v 1 homologues are allergens in kiwifruit and of relevance for patients sensitized to tree pollen and kiwifruit, and might have been neglected so far due to low abundance in the conventional extracts used for diagnosis.
引用
收藏
页码:S230 / S240
页数:11
相关论文
共 50 条
  • [21] Oropharyngeal symptoms to bell pepper in an adult patient with Bet V 1-related allergy
    Vieru, M.
    Ganea, C. S.
    Popescu, F. D.
    ALLERGY, 2019, 74 : 843 - 843
  • [22] A transgenic Bet v 1142-153-specific T-cell antigen receptor cross-reacts with Bet v 1-related pollen and food allergens
    Neunkirchner, A.
    Leb-Reichl, V
    Schmetterer, K.
    Mutschlechner, S.
    Kueng, H.
    Haiderer, D.
    Wallner, M.
    Jahn-Schmid, B.
    Bohle, B.
    Pickl, W.
    ALLERGY, 2010, 65 : 162 - 163
  • [23] Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy
    Batard, T
    Didierlaurent, A
    Chabre, H
    Mothes, N
    Bussières, L
    Bohle, B
    Couret, MN
    Ball, T
    Lemoine, P
    Tejkl, MF
    Chenal, A
    Clément, G
    Dupont, F
    Valent, P
    Krauth, MT
    André, C
    Valenta, R
    Moingeon, P
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 136 (03) : 239 - 249
  • [24] X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy
    Gajhede, M
    Osmark, P
    Poulsen, FM
    Ipsen, H
    Larsen, JN
    vanNeerven, RJJ
    Schou, C
    Lowenstein, H
    Spangfort, MD
    NATURE STRUCTURAL BIOLOGY, 1996, 3 (12): : 1040 - 1045
  • [25] Soy allergy due to cross reactions to major birch pollen allergen Bet v 1
    Kleine-Tebbe, J.
    Herold, D. A.
    Vieths, S.
    ALLERGOLOGIE, 2008, 31 (08) : 303 - 313
  • [26] IgE, IgG4 and IgA specific to Bet v 1-related food allergens do not predict oral allergy syndrome
    Guhsl, E. E.
    Hofstetter, G.
    Lengger, N.
    Hemmer, W.
    Ebner, C.
    Froeschl, R.
    Bublin, M.
    Lupinek, C.
    Breiteneder, H.
    Radauer, C.
    ALLERGY, 2015, 70 (01) : 59 - 66
  • [27] Allergy vaccine development using the birch pollen major allergen Bet v 1 as example
    Wallner, M.
    Hauser, M.
    ALLERGOLOGIE, 2012, 35 (02) : 88 - 94
  • [28] The major birch pollen allergen Bet v 1 binds lipids from birch and grass pollen but not from peanuts
    Gepp, B.
    Ackerbauer, D.
    Lengger, N.
    Gruber, F.
    Mildner, M.
    Breiteneder, H.
    ALLERGY, 2014, 69 : 464 - 464
  • [29] Efficacy and safety of 4 months of sublingual immunotherapy with recombinantMal d 1 and Bet v 1 in patients with birch pollen-related apple allergy
    Kinaciyan, Tamar
    Nagl, Birgit
    Faustmann, Sandra
    Frommlet, Florian
    Kopp, Stephan
    Wolkersdorfer, Martin
    Woehrl, Stefan
    Bastl, Katharina
    Huber, Hans
    Berger, Uwe
    Bohle, Barbara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (03) : 1002 - 1008
  • [30] Bet v 1 and other birch allergens are more resistant to proteolysis and more abundant than other birch pollen proteins
    Cabrera, Aurora
    Foo, Alexander C. Y.
    Fitzgerald, Michael C.
    Mueller, Geoffrey A.
    ALLERGY, 2022, 77 (04) : 1307 - 1309